ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 133 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,793 | -28.9% | 887 | 0.0% | 0.00% | – |
| Q2 2023 | $25,023 | +209.5% | 887 | +88.7% | 0.00% | – |
| Q1 2023 | $8,084 | +1333.3% | 470 | +1578.6% | 0.00% | – |
| Q4 2022 | $564 | -43.6% | 28 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -97.2% | 28 | -97.8% | 0.00% | – |
| Q2 2022 | $36,000 | -46.3% | 1,276 | -12.1% | 0.00% | – |
| Q1 2022 | $67,000 | +168.0% | 1,451 | +378.9% | 0.00% | – |
| Q4 2021 | $25,000 | – | 303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |